medigraphic.com

2024, Number 1

<< Back Next >>

rev homeostasis 2024; 6 (1)

Síndrome de Alarma Capsular: Una revisión de la literatura

Flores VRF, Zamanillo TJP, Soto MA, Del Río MXI, García RAD, García BAE

Language: Spanish
References: 20
Page:
PDF size: 182.85 Kb.


ABSTRACT

Capsular Warning Syndrome (CAS) refers to a series of recurrent transient ischemic attacks (TIAS) that significantly increase the risk of a heart attack. This syndrome manifests through repeated episodes of transient, focal neurological deficits, which trigger symptoms affecting sensation and movement in the face, arms, and legs. This occurs without the presence of signs of cortical involvement. To date, little is known about the nature and management of this syndrome. However, various theories have been proposed to explain its cause, Such as small vessel disease artery-to-artery embolism, hemodynamic instability, and peri-infarct depolarization. AII of these could contributte to its origin. At present, there is no standardized guideline for treatment; however, different therapeutic approaches hae been considered. These include the Combination of antiplatelet agents and statins, as well as the possibility of using anticoagulants, thrombolysis, or blood pressure stabilization to avoid episodes of hypotension (1.2)


REFERENCES

  1. Sales C, Calma AD. Stroke warningsyndrome. Clin Neurol Neurosurg. el 1 defebrero de 2022;213.

  2. Sen A, Birns J, Bhalla A. Stroke warningsyndromes. Br J Hosp Med. el 2 de enerode 2020;81(1):1–5.

  3. Donnan GA, O’Malley HM, Quang L,Hurley S, Bladin PF. The capsular warningsyndrome: Pathogenesis and clinicalfeatures. Neurology. 1993;43(5):957–62.

  4. He L, Xu R, Wang J, Zhang L, Zhang L,Zhou F, et al. Capsular warningsyndrome: Clinical analysis andtreatment. BMC Neurol. el 13 denoviembre de 2019;19(1).

  5. Camps-Renom P, Delgado-Mederos R,Martínez-Domeño A, Prats-Sánchez L,Cortés-Vicente E, Simón-Talero M, et al.Clinical characteristics and outcome of thecapsular warning syndrome: Amulticenter study. International Journal ofStroke. el 1 de junio de2015;10(4):571–5.

  6. Kim JG, Choi H, Sohn SY, Kim DH, Lee SJ.Transient ischemic attacks precedingacute lacunar infarction. Eur Neurol. el 1de noviembre de 2016;76(5–6):278–83.

  7. Lalive PH, Mayor I, Sztajzel R. The role ofblood pressure in lacunar strokespreceded by TIAs. CerebrovascularDiseases. 2003;16(1):88–90.

  8. Staaf G, Geijer B, Lindgren A, Norrving B.Diffusion-weighted MRI findings inpatients with capsular warning syndrome.Cerebrovascular Diseases.2004;17(1):1–8.

  9. Nicola LMP, Simoni M, Chandratheva A,Rothwell PM. Population-based study ofcapsular warning syndrome andprognosis after early recurrent TIA.Neurology. el 25 de septiembre de2012;79(13):1356–62.

  10. Gennai S, Giordano-Orsini G, Lefour S,Cuisenier P. Transient Ischemic Attack:Limits and challenges of earlymanagement. Presse Medicale. el 1 denoviembre de 2018;47(11-12P1):934–7.

  11. Powers WJ, Rabinstein AA, Ackerson T,Adeoye OM, Bambakidis NC, Becker K,et al. Guidelines for the earlymanagement of patients with acuteischemic stroke: 2019 update to the 2018guidelines for the early management ofacute ischemic stroke a guideline forhealthcare professionals from theAmerican Heart Association/AmericanStroke Association. Stroke. el 1 dediciembre de 2019;50(12):E344–418.

  12. Kleindorfer DO, Towfighi A, Chaturvedi S,Cockroft KM, Gutierrez J, Lombardi-Hill D,et al. 2021 Guideline for the prevention ofstroke in patients with stroke andtransient ischemic attack; A guidelinefrom the American HeartAssociation/American Stroke Association.Stroke. el 1 de julio de 2021;E364–467.

  13. Cutting S, Regan E, Lee VH, PrabhakaranS. High ABCD2 Scores and In-HospitalInterventions following TransientIschemic Attack. Cerebrovasc Dis Extra. el7 de septiembre de 2016;6(3):76–83.

  14. Hurford R, Li L, Lovett N, Kubiak M, KukerW, Rothwell PM. Prognostic value of“tissue-based” definitions of TIA andminor stroke: Population-based study.Neurology. el 21 de mayo de2019;92(21):e2455–61.

  15. Aiba Y, Sakakibara R, Tateno F, Ogata T,Nagao T, Terada H, et al. TransientIschemic Attack: Which DeterminesDiffusion-Weighted Image Positivity?Journal of Stroke and CerebrovascularDiseases. el 1 de diciembre de2019;28(12).

  16. Perry JJ, Yadav K, Syed S, Shamy M.Transient ischemic attack and minorstroke: diagnosis, risk stratification andmanagement. CMAJ Canadian MedicalAssociation Journal. el 11 de octubre de2022;194(39):E1344–9.

  17. Asil T, Ir N, Karaduman F, Cagli B, TuncelS. Combined antithrombotic treatmentwith aspirin and clopidogrel for patientswith capsular warning syndrome: A casereport. Neurologist. marzo de2012;18(2):68–9.

  18. Fuseya Y, Kawamura M, Matsuda E,Takada K, Watanabe K, Fujitake J, et al.Rt-pa with antithrombotic therapies in acase with capsular warning syndrome.Internal Medicine. 2017;56(4):441–4.

  19. Xu J, Zhuang M, Bao G, Zhai Y, Yang GY,Xue G, et al. R-tPA with loading dose ofclopidogrel and aspirin therapies forcapsular warning syndrome attributed tomiddle cerebral artery atheroscleroticstenosis: A CARE-compliant case report.Medicine (United States). 2020;99(9).

  20. Liu Y, Li S, Hao D, Zhang Z, Yi Y, Fang J,et al. Clinical safety and possible efficacyof tirofiban in combination withintravenous thrombolysis by recombinanttissue




2020     |     www.medigraphic.com